Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients.

Olivia Le SauxAurélie BourmaudCatherine RioufolOlivier ColombanJérôme GuittonVérane SchwiertzVéronique RegnierBenoit YouFlorence RanchonRaymonde Maraval-GagetPascal GirardFranck ChauvinGilles FreyerMichel TodEmilie HeninVéronique Trillet-Lenoir

Published in: Cancer chemotherapy and pharmacology (2018)

Adherence to oral anticancer chemotherapy was found excellent in this population suggesting over-adherence to capecitabine and potential safety implications for outpatients' drugs.

Keyphrases

locally advanced
phase ii study
glycemic control
metastatic breast cancer
human health
metastatic colorectal cancer
squamous cell carcinoma
type diabetes
clinical trial
radiation therapy
metabolic syndrome
insulin resistance
skeletal muscle
weight loss
double blind